{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:54:30Z","timestamp":1789768470416,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","award":["CPU2018GY33"],"award-info":[{"award-number":["CPU2018GY33"]}],"id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20221526"],"award-info":[{"award-number":["BK20221526"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.intimp.2023.111150","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T01:24:39Z","timestamp":1698974679000},"page":"111150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"PA","title":["Modulating intestinal barrier function by sphingosine-1-phosphate receptor 1 specific agonist SEW2871 attenuated ANIT-induced cholestatic hepatitis via the gut-liver axis"],"prefix":"10.1016","volume":"125","author":[{"given":"Tingting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-4325","authenticated-orcid":false,"given":"Zhenzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2018.09.007","article-title":"Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases","volume":"24","author":"Yang","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.intimp.2023.111150_b0010","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2023.111150_b0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jsbmb.2017.05.015","article-title":"Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids","volume":"172","author":"Yang","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2023.111150_b0020","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/liv.14906","article-title":"A nonbile acid farnesoid X receptor agonist tropifexor potently inhibits cholestatic liver injury and fibrosis by modulating the gut-liver axis","volume":"41","author":"Xiao","year":"2021","journal-title":"Liver Int.: Off. J. Int. Assoc. Study Liver"},{"issue":"3","key":"10.1016\/j.intimp.2023.111150_b0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbamem.2006.10.008","article-title":"Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis","volume":"1768","author":"Slitt","year":"2007","journal-title":"BBA"},{"issue":"3","key":"10.1016\/j.intimp.2023.111150_b0030","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2015.10.024","article-title":"Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis","volume":"64","author":"Baghdasaryan","year":"2016","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0035","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1038\/s41598-018-25214-0","article-title":"Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis","volume":"8","author":"Al-Dury","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2023.111150_b0040","first-page":"2090","article-title":"Intestinal Microbiome-Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice, Hepatology (Baltimore","volume":"72","author":"Isaacs-Ten","year":"2020","journal-title":"Md.)"},{"key":"10.1016\/j.intimp.2023.111150_b0045","doi-asserted-by":"crossref","unstructured":"Y. Wang, X. Gao, X. Zhang, Y. Xiao, J. Huang, D. Yu, X. Li, H. Hu, T. Ge, D. Li, T. Zhang, Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis, mSystems 4(6) (2019).","DOI":"10.1128\/msystems.00463-19"},{"issue":"6","key":"10.1016\/j.intimp.2023.111150_b0050","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0055","first-page":"e13357","article-title":"Regulation of the intestinal barrier by nutrients: The role of tight junctions","volume":"91","author":"Suzuki","year":"2020","journal-title":"Animal Sci. J. = Nihon Chikusan Gakkaiho"},{"issue":"11","key":"10.1016\/j.intimp.2023.111150_b0060","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111150_b0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2362.2010.02379.x","article-title":"Intestinal epithelial cell proliferation, apoptosis and expression of tight junction proteins in patients with obstructive jaundice","volume":"41","author":"Assimakopoulos","year":"2011","journal-title":"Eur. J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.intimp.2023.111150_b0070","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1053\/j.gastro.2012.07.099","article-title":"Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice","volume":"143","author":"Hartmann","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/jam.15135","article-title":"Butyrate administration strengthens the intestinal epithelium and improves intestinal dysbiosis in a cholestasis fibrosis model","volume":"132","author":"Pe\u00f1a-Rodr\u00edguez","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.intimp.2023.111150_b0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharmthera.2016.09.008","article-title":"Targeting sphingosine-1-phosphate signaling in lung diseases","volume":"168","author":"Ebenezer","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.livres.2019.02.003","article-title":"Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases","volume":"3","author":"Kwong","year":"2019","journal-title":"Liver Research"},{"key":"10.1016\/j.intimp.2023.111150_b0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.toxlet.2020.06.018","article-title":"Sphingosine 1-phosphate receptor-1 specific agonist SEW2871 ameliorates ANIT-induced dysregulation of bile acid homeostasis in mice plasma and liver","volume":"331","author":"Yang","year":"2020","journal-title":"Toxicol. Lett."},{"issue":"4","key":"10.1016\/j.intimp.2023.111150_b0095","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10565-020-09567-9","article-title":"SEW2871 attenuates ANIT-induced hepatotoxicity by protecting liver barrier function via sphingosine 1-phosphate receptor-1-mediated AMPK signaling pathway","volume":"37","author":"Yang","year":"2021","journal-title":"Cell Biol. Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111150_b0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12026-015-8625-5","article-title":"SEW2871 protects from experimental colitis through reduced epithelial cell apoptosis and improved barrier function in interleukin-10 gene-deficient mice","volume":"61","author":"Dong","year":"2015","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/cei.12304","article-title":"Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice","volume":"177","author":"Dong","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"14","key":"10.1016\/j.intimp.2023.111150_b0110","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1074\/jbc.M311743200","article-title":"Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate","volume":"279","author":"Sanna","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.intimp.2023.111150_b0115","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/sj.ki.5000360","article-title":"S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure","volume":"69","author":"Lien","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2023.111150_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106100","article-title":"Comparison of bile acids profiles in the enterohepatic circulation system of mice and rats","volume":"220","author":"Duan","year":"2022","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.intimp.2023.111150_b0125","article-title":"High glucose exposure drives intestinal barrier dysfunction by altering its morphological, structural and functional properties","volume":"115765","author":"Dubois","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"16","key":"10.1016\/j.intimp.2023.111150_b0130","doi-asserted-by":"crossref","first-page":"7520","DOI":"10.1039\/D3FO01094E","article-title":"Garlic-derived exosome-like nanovesicles alleviate dextran sulphate sodium-induced mouse colitis via the TLR4\/MyD88\/NF-\u03baB pathway and gut microbiota modulation","volume":"14","author":"Zhu","year":"2023","journal-title":"Food Funct."},{"issue":"12","key":"10.1016\/j.intimp.2023.111150_b0135","doi-asserted-by":"crossref","first-page":"10675","DOI":"10.1039\/D0FO01954B","article-title":"Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db\/db mice","volume":"11","author":"Yang","year":"2020","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1113\/expphysiol.2014.082149","article-title":"Differential activation of receptors and signal pathways upon stimulation by different doses of sphingosine-1-phosphate in endothelial cells","volume":"100","author":"Li","year":"2015","journal-title":"Exp. Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111150_b0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.it.2007.01.007","article-title":"Tipping the gatekeeper: S1P regulation of endothelial barrier function","volume":"28","author":"Rosen","year":"2007","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.111150_b0150","first-page":"1317","article-title":"Liver kinase B1 regulates hepatocellular tight junction distribution and function in vivo, Hepatology (Baltimore","volume":"64","author":"Porat-Shliom","year":"2016","journal-title":"Md.)"},{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0155","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00204-016-1697-8","article-title":"Role of AMP-activated protein kinase \u03b11 in 17\u03b1-ethinylestradiol-induced cholestasis in rats","volume":"91","author":"Li","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"8","key":"10.1016\/j.intimp.2023.111150_b0160","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky gut: mechanisms, measurement and clinical implications in humans","volume":"68","author":"Camilleri","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.intimp.2023.111150_b0165","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1021\/acsptsci.1c00052","article-title":"Compensatory Transition of Bile Acid Metabolism from Fecal Disposition of Secondary Bile Acids to Urinary Excretion of Primary Bile Acids Underlies Rifampicin-Induced Cholestasis in Beagle Dogs","volume":"4","author":"Gui","year":"2021","journal-title":"ACS Pharmacology & Translational Science"},{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0170","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1038\/s41467-019-12896-x","article-title":"Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism","volume":"10","author":"Huang","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2023.111150_b0175","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s12072-021-10138-1","article-title":"Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease","volume":"15","author":"Xu","year":"2021","journal-title":"Hepatol Int"},{"issue":"10074","key":"10.1016\/j.intimp.2023.111150_b0180","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0140-6736(17)30319-7","article-title":"Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study","volume":"389","author":"Hegade","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.intimp.2023.111150_b0185","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00018-014-1762-5","article-title":"Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling","volume":"72","author":"P\u0142\u00f3ciennikowska","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2023.111150_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115119","article-title":"Protective effect of Amomum Roxb. essential oils in lipopolysaccharide-induced acute lung injury mice and its metabolomics","volume":"290","author":"Zhao","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2023.111150_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108679","article-title":"Atractyloside-A ameliorates spleen deficiency diarrhea by interfering with TLR4\/MyD88\/NF-\u03baB signaling activation and regulating intestinal flora homeostasis","volume":"107","author":"Xu","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111150_b0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3727\/105221619X15469715711907","article-title":"Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology","volume":"19","author":"Pradhan-Sundd","year":"2019","journal-title":"Gene Expr."},{"issue":"3","key":"10.1016\/j.intimp.2023.111150_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/nu13031018","article-title":"The Gut-Liver Axis in Cholestatic Liver Diseases","volume":"13","author":"Blesl","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/gutjnl-2018-316975","article-title":"TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function","volume":"69","author":"Merlen","year":"2020","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.intimp.2023.111150_b0215","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jhep.2018.04.009","article-title":"Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis","volume":"69","author":"Pollheimer","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2023.111150_b0220","doi-asserted-by":"crossref","unstructured":"S.P. Amarachintha, R. Mourya, H. Ayabe, L. Yang, Z. Luo, X. Li, U. Thanekar, P. Shivakumar, J.A. Bezerra, Biliary organoids uncover delayed epithelial development and barrier function in biliary atresia, Hepatology (Baltimore, Md.) 75(1) (2022) 89-103.","DOI":"10.1002\/hep.32107"},{"issue":"3","key":"10.1016\/j.intimp.2023.111150_b0225","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00795-003-0220-5","article-title":"Regulation of the blood-biliary barrier: interaction between gap and tight junctions in hepatocytes","volume":"36","author":"Kojima","year":"2003","journal-title":"Medical Electron Microscopy: Off. J. Clin. Electron Microscopy Soc. Japan"},{"key":"10.1016\/j.intimp.2023.111150_b0230","doi-asserted-by":"crossref","unstructured":"R.T. Khalaf, R.J. Sokol, New Insights Into Intestinal Failure-Associated Liver Disease in Children, Hepatology (Baltimore, Md.) 71(4) (2020) 1486-1498.","DOI":"10.1002\/hep.31152"},{"key":"10.1016\/j.intimp.2023.111150_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2017.09.051","article-title":"Early indications of ANIT-induced cholestatic liver injury: Alteration of hepatocyte polarization and bile acid homeostasis","volume":"110","author":"Yang","year":"2017","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"10.1016\/j.intimp.2023.111150_b0240","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00383-011-2989-y","article-title":"Effect of alpha-naphthylisothiocyanate-induced liver injury on intestinal adaptation in a rat model of short bowel syndrome","volume":"28","author":"Sukhotnik","year":"2012","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.intimp.2023.111150_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2021.103672","article-title":"Intrahepatic cholestasis induced by \u03b1-naphthylisothiocyanate can cause gut-liver axis disorders","volume":"86","author":"Chen","year":"2021","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111150_b0250","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1053\/j.gastro.2021.01.027","article-title":"Protective Functions of ZO-2\/Tjp2 Expressed in Hepatocytes and Cholangiocytes Against Liver Injury and Cholestasis","volume":"160","author":"Xu","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.intimp.2023.111150_b0255","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajpath.2014.10.009","article-title":"The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats","volume":"185","author":"Verbeke","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.intimp.2023.111150_b0260","doi-asserted-by":"crossref","first-page":"29454","DOI":"10.3390\/ijms161226177","article-title":"Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model","volume":"16","author":"Schuhmann","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.111150_b0265","doi-asserted-by":"crossref","unstructured":"Y. Wang, H. Aoki, J. Yang, K. Peng, R. Liu, X. Li, X. Qiang, L. Sun, E.C. Gurley, G. Lai, L. Zhang, G. Liang, M. Nagahashi, K. Takabe, W.M. Pandak, P.B. Hylemon, H. Zhou, The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice, Hepatology (Baltimore, Md.) 65(6) (2017) 2005-2018.","DOI":"10.1002\/hep.29076"},{"key":"10.1016\/j.intimp.2023.111150_b0270","doi-asserted-by":"crossref","first-page":"9673512","DOI":"10.1155\/2022\/9673512","article-title":"Fibroblast Growth Factor 19 Improves LPS-Induced Lipid Disorder and Organ Injury by Regulating Metabolomic Characteristics in Mice","volume":"2022","author":"Liu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"23","key":"10.1016\/j.intimp.2023.111150_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236012","article-title":"Reciprocal Association between the Apical Junctional Complex and AMPK: A Promising Therapeutic Target for Epithelial\/Endothelial Barrier Function?","volume":"20","author":"Tsukita","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.111150_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115248","article-title":"Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway","volume":"408","author":"Li","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2023.111150_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118405","article-title":"Palmatine regulates bile acid cycle metabolism and maintains intestinal flora balance to maintain stable intestinal barrier","volume":"262","author":"Ning","year":"2020","journal-title":"Life Sci."},{"issue":"25","key":"10.1016\/j.intimp.2023.111150_b0290","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.3748\/wjg.15.3134","article-title":"Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease","volume":"15","author":"Gnewuch","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111150_b0295","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cld.2018.12.009","article-title":"Intestinal Failure-Associated Liver Disease","volume":"23","author":"Pironi","year":"2019","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.intimp.2023.111150_b0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12072-020-10048-8","article-title":"Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management","volume":"14","author":"Lee","year":"2020","journal-title":"Hepatol. Int."},{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5217\/ir.2017.15.1.118","article-title":"El Gezawy, Intestinal barrier integrity and function in infants with cholestasis","volume":"15","author":"Abu Faddan","year":"2017","journal-title":"Intestinal Research"},{"issue":"12","key":"10.1016\/j.intimp.2023.111150_b0310","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1097\/MIB.0000000000000204","article-title":"Intestinal inflammation and mucosal barrier function","volume":"20","author":"S\u00e1nchez de Medina","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"issue":"7","key":"10.1016\/j.intimp.2023.111150_b0315","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s41401-020-0497-0","article-title":"Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease","volume":"42","author":"Prados","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2023.111150_b0320","article-title":"Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: A troublesome trio for acute pancreatitis","volume":"132","author":"Ge","year":"2020","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"3","key":"10.1016\/j.intimp.2023.111150_b0325","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bph.14095","article-title":"Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111150_b0330","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1172\/JCI92390","article-title":"FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.intimp.2023.111150_b0335","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gutjnl-2017-314759","article-title":"Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression","volume":"67","author":"Stevens","year":"2018","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.intimp.2023.111150_b0340","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2023.111150_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118750","article-title":"Lauric acid ameliorates lipopolysaccharide (LPS)-induced liver inflammation by mediating TLR4\/MyD88 pathway in Sprague Dawley (SD) rats","volume":"265","author":"Khan","year":"2021","journal-title":"Life Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923014765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923014765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:08:10Z","timestamp":1761588490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923014765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":69,"alternative-id":["S1567576923014765"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111150","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating intestinal barrier function by sphingosine-1-phosphate receptor 1 specific agonist SEW2871 attenuated ANIT-induced cholestatic hepatitis via the gut-liver axis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111150"}}